Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Ren Nutr. 2019 Jan 21;29(5):428–437. doi: 10.1053/j.jrn.2018.11.002

Table 2.

Mean Phosphate Binder Pill Burden Stratified by Serum Phosphorus Categories

PPD by sP (mg/dL) Categories at Specified Study Quarters
Time Period ≤5.5 5.6–6.5 6.6–7.5 7.6–8.5 >8.5
Baseline (−Q1) 7.3 (4.0) 8.0 (3.9) 8.8 (4.1) 9.0 (3.7) 9.8 (4.4)
SO follow-up Q1 3.8 (1.7) 4.0 (1.6) 4.3 (1.8) 4.4 (1.7) 4.2 (1.6)
SO follow-up Q2 3.9 (1.7) 3.9 (1.5) 4.7 (2.1) 4.4 (2.0) 4.3 (1.4)
SO follow-up Q3 4.1 (1.8) 4.4 (1.9) 4.4 (1.8) 4.3 (1.9) 4.7 (2.2)
SO follow-up Q4 4.0 (1.8) 4.5 (1.8) 4.6 (2.2) 4.3 (2.0) 4.8 (2.0)

PPD, pills per day; SO, sucroferric oxyhydroxide; sP, serum phosphorus.

Summary estimates are presented as mean (standard deviation).